Smartstop Self Storage REIT Inc (NYSE:SMA) Receives $36.31 Consensus Price Target from Analysts

Smartstop Self Storage REIT Inc (NYSE:SMA) has been assigned an average recommendation of “Moderate Buy” from the ten research firms that are covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation, four have issued a buy recommendation and two have issued a strong buy recommendation on the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $36.4375.

SMA has been the topic of several recent research reports. Zacks Research raised Smartstop Self Storage REIT from a “strong sell” rating to a “hold” rating in a report on Friday, May 8th. Weiss Ratings upgraded Smartstop Self Storage REIT from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 16th. Raymond James Financial began coverage on Smartstop Self Storage REIT in a research report on Wednesday, July 15th. They issued a “strong-buy” rating and a $39.00 target price for the company. Finally, Wells Fargo & Company reiterated a “neutral” rating on shares of Smartstop Self Storage REIT in a research note on Friday.

Smartstop Self Storage REIT Stock Up 3.1%

NYSE SMA opened at $34.73 on Friday. The company has a debt-to-equity ratio of 0.86, a quick ratio of 5.33 and a current ratio of 5.33. The firm has a 50-day simple moving average of $32.37 and a 200 day simple moving average of $32.14. Smartstop Self Storage REIT has a twelve month low of $29.41 and a twelve month high of $39.77. The stock has a market cap of $1.92 billion, a PE ratio of 231.53 and a beta of 0.56.

Smartstop Self Storage REIT (NYSE:SMA) last issued its quarterly earnings results on Wednesday, May 6th. The healthcare company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.01. The firm had revenue of $78.31 million for the quarter, compared to analyst estimates of $72.56 million. Smartstop Self Storage REIT had a return on equity of 1.00% and a net margin of 4.38%.Smartstop Self Storage REIT’s quarterly revenue was up 19.7% compared to the same quarter last year. Smartstop Self Storage REIT has set its FY 2026 guidance at 1.940-2.040 EPS. On average, research analysts forecast that Smartstop Self Storage REIT will post 2 EPS for the current year.

Smartstop Self Storage REIT Increases Dividend

The firm also recently disclosed a monthly dividend, which will be paid on Friday, August 14th. Stockholders of record on Friday, July 31st will be issued a dividend of $0.1359 per share. This represents a c) dividend on an annualized basis and a dividend yield of 4.7%. The ex-dividend date of this dividend is Friday, July 31st. This is a positive change from Smartstop Self Storage REIT’s previous monthly dividend of $0.13. Smartstop Self Storage REIT’s payout ratio is 1,053.33%.

Institutional Trading of Smartstop Self Storage REIT

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. JPMorgan Chase & Co. acquired a new position in Smartstop Self Storage REIT in the second quarter worth about $3,155,000. New York State Common Retirement Fund acquired a new stake in Smartstop Self Storage REIT during the second quarter valued at approximately $326,000. Quantbot Technologies LP acquired a new stake in Smartstop Self Storage REIT during the second quarter valued at approximately $377,000. Invesco Ltd. bought a new stake in shares of Smartstop Self Storage REIT in the 2nd quarter valued at approximately $602,000. Finally, Marshall Wace LLP bought a new stake in shares of Smartstop Self Storage REIT in the 2nd quarter valued at approximately $830,000.

About Smartstop Self Storage REIT

Symmetry Medical Inc (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry.